Kommuniqué V, 20-23 September 2020
Liebe Aktionäre, Freunde, Während die Welt darum kämpft, die Verbreitung von...
Read MoreCLINUVEL Newsletter V
Dear shareholders, friends, As the world battles on to control the...
Read MoreCLINUVEL CONFIRMS AGM DATE
Melbourne, Australia, 23 September 2020 CLINUVEL PHARMACEUTICALS LTD today announces it will...
Read MoreOpening of VALLAURIX R&D facilities in Singapore
Advanced research facilities to progress pharmaceutical, OTC products EXECUTIVE SUMMARY • CLINUVEL...
Read MoreMedia Release – CLINUVEL opens VALLAURIX R&D centre in Singapore
The CLINUVEL Group today announced the opening of its state-of-the-art centralised Research&...
Read MoreLapse and Forfeit of Unlisted Conditional Performance Rights
CLINUVEL PHARMACEUTICALS LTD wishes to advise in accordance with the terms and...
Read MoreAppendix 4C
CLINUVEL PHARMACEUTICALS LTD, a global biopharmaceutical company focused on developing and delivering...
Read MoreCLINUVEL Kommuniqué I
Sehr geehrte Aktionärinnen und Aktionäre, liebe Freunde Im Namen des CLINUVEL-Ausschusses wünsche...
Read MoreCLINUVEL Newsletter
Dear shareholders, friends On behalf of the CLINUVEL Board, I wish you...
Read More